TABLE 2.
Relevant genotypea | Autoagglutination | CT secretion (ng/ml of supernatant/OD600) | TCP (CTX φ-Cm transductants/ml/OD600) | Polymyxin B MIC (μg/ml) | Serum resistance (no. of survivors relative to wild type/OD600) | CT-B localization (% total)
|
|
---|---|---|---|---|---|---|---|
Cells | Medium | ||||||
Wild type | + | 594 | 3.8 × 105 | 0.30 | 1.0 | 0.3 | 99.7 |
ΔompU1 | − | 17.8 | 5.9 × 104 | 0.15 | 0.97 | 2.9 | 97.1 |
ΔompU2 | + | 307 | 1.4 × 105 | 0.30 | 0.84 | 0.3 | 99.7 |
ΔompU2 ΔompT | + | 104 | 1.1 × 105 | 0.30 | 1.36 | 1.1 | 98.9 |
ΔompT | + | 211 | 1.6 × 105 | 0.30 | 1.06 | 0.6 | 99.4 |
ΔtoxR | − | 0 | 0 | 0.60 | 0.54 | 0.1 | 99.9 |
ΔtoxR ΔompT | − | 0 | 0 | 0.30 | 1.27 | 1.6 | 98.4 |
ΔepsD | + | 43.8 | 2.7 × 105 | NDb | ND | 70.5 | 29.5 |
ΔepsE | + | NDb | 1.5 × 105 | ND | ND | 74.9 | 25.1 |
The actual strains used (described in the text) were O395, KKV669, KKV780, KKV884, KKV809, KKV61, KKV804, KKV1216, and KKV1234.
ND, not determined.